{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:18:56Z","timestamp":1723335536786},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Finnish Funding Agency","award":["70036\/11","70051\/10"],"award-info":[{"award-number":["70036\/11","70051\/10"]}]},{"DOI":"10.13039\/100007753","name":"University of Eastern Finland Spearhead Project UEF-Brain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neuropharm.2017.03.024","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T21:49:00Z","timestamp":1490219340000},"page":"15-25","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat"],"prefix":"10.1016","volume":"119","author":[{"given":"Jaakko","family":"Paasonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimo A.","family":"Salo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouni","family":"Ihalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juuso V.","family":"Leikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus M.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Gr\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mrm.1910340409","article-title":"Functional connectivity in the motor cortex of resting human brain using echo-planar MRI","volume":"34","author":"Biswal","year":"1995","journal-title":"Magnetic Reson. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2017.03.024_bib2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1023\/A:1011992125204","article-title":"Methodological aspects of the use of a calibrator in in\u00a0vivo microdialysis-further development of the retrodialysis method","volume":"15","author":"Bouw","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2017.03.024_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2013.04.026","article-title":"A\u00a0schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by magnetic resonance imaging","volume":"250","author":"Broberg","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2017.03.024_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.neuropharm.2005.05.013","article-title":"Effects of novel antipsychotics with mixed D(2) antagonist\/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat","volume":"49","author":"Bruins Slot","year":"2005","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2017.03.024_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mrm.21779","article-title":"Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats","volume":"61","author":"Bruns","year":"2009","journal-title":"Magnetic Reson. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0028-3908(81)90011-3","article-title":"Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat","volume":"20","author":"Castellani","year":"1981","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib7","doi-asserted-by":"crossref","first-page":"e2004","DOI":"10.1371\/journal.pone.0002004","article-title":"Cyclic and sleep-like spontaneous alternations of brain state under urethane anaesthesia","volume":"3","author":"Clement","year":"2008","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.286.4.427","article-title":"Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors","volume":"286","author":"Crespo-Facorro","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0269881114563635","article-title":"Functional brain connectivity phenotypes for schizophrenia drug discovery","volume":"29","author":"Dawson","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-010-1945-1","article-title":"A\u00a0within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists","volume":"212","author":"Dix","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2017.03.024_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(99)01776-X","article-title":"Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine","volume":"843","author":"Duncan","year":"1999","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2017.03.024_bib13","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.euroneuro.2014.08.012","article-title":"Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia","volume":"24","author":"Fellini","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2017.03.024_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrn2201","article-title":"Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging","volume":"8","author":"Fox","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib15","first-page":"89","article-title":"Schizophrenia: a disconnection syndrome?","volume":"3","author":"Friston","year":"1995","journal-title":"Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/npp.2013.290","article-title":"Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat","volume":"39","author":"Gass","year":"2014","journal-title":"Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.03.024_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuropharm.2011.03.015","article-title":"NMDA receptors, cognition and schizophrenia\u2013testing the validity of the NMDA receptor hypofunction hypothesis","volume":"62","author":"Gilmour","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-009-1530-7","article-title":"Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for \u201cNMDA antagonist modelling\u201d of schizophrenia","volume":"205","author":"Gilmour","year":"2009","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2017.03.024_bib19","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/sj.npp.1301547","article-title":"Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine","volume":"33","author":"Gozzi","year":"2008","journal-title":"Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2010.02.057","article-title":"Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation","volume":"168","author":"Hackler","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1213\/00000539-200202000-00015","article-title":"The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels","volume":"94","author":"Hara","year":"2002","journal-title":"Anesth. Analgesia"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2016.02.032","article-title":"Comparison of phencyclidine-induced spatial learning and memory deficits and reversal by sertindole and risperidone between lister hooded and wistar rats","volume":"305","author":"Ihalainen","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"21\u201322","key":"10.1016\/j.neuropharm.2017.03.024_bib23","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00213-015-3954-6","article-title":"The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia","volume":"232","author":"Janhunen","year":"2015","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2017.03.024_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2017.03.024_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia is a cognitive illness: time for a change in focus","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pnpbp.2007.09.008","article-title":"Comparison between intraperitoneal and subcutaneous phencyclidine administration in sprague-dawley rats: a locomotor activity and gene induction study","volume":"32","author":"Kalinichev","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Psychiatry"},{"issue":"37","key":"10.1016\/j.neuropharm.2017.03.024_bib27","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/brain.2015.0365","article-title":"Spin-echo resting-state functional connectivity in high-susceptibility regions: accuracy, reliability, and the impact of physiological noise","volume":"6","author":"Khatamian","year":"2016","journal-title":"Brain Connect."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2017.03.024_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuroimage.2015.05.018","article-title":"Deep neural network with weight sparsity control and pre-training extracts hierarchical features and enhances classification performance: evidence from whole-brain resting-state functional connectivity patterns of schizophrenia","volume":"124","author":"Kim","year":"2016","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0079-6123(05)50022-0","article-title":"Functional brain imaging of symptoms and cognition in schizophrenia","volume":"150","author":"Kircher","year":"2005","journal-title":"Prog. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.03.024_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881107077712","article-title":"Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?","volume":"21","author":"Large","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2017.03.024_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/(SICI)1522-2594(199911)42:5<919::AID-MRM12>3.0.CO;2-8","article-title":"Diffusion-weighted spin-echo fMRI at 9.4 T: Microvascular\/tissue contribution to BOLD signal changes","volume":"42","author":"Lee","year":"1999","journal-title":"Magnetic Reson. Med."},{"key":"10.1016\/j.neuropharm.2017.03.024_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2008.01.016","article-title":"Imaging brain activation in nicotine-sensitized rats","volume":"1199","author":"Li","year":"2008","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.pbb.2011.03.023","article-title":"Glutamate signaling in the pathophysiology and therapy of schizophrenia","volume":"100","author":"Lin","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00213-006-0344-0","article-title":"Mapping the central effects of ketamine in the rat using pharmacological MRI","volume":"186","author":"Littlewood","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2013.08.023","article-title":"Resting state functional connectivity: its physiological basis and application in neuropharmacology","volume":"84","author":"Lu","year":"2014","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2017.03.024_bib37","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1073\/pnas.1200506109","article-title":"Rat brains also have a default mode network","volume":"109","author":"Lu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.neuropharm.2017.03.024_bib38","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1523\/JNEUROSCI.0333-10.2010","article-title":"Functional connectivity and brain networks in schizophrenia","volume":"30","author":"Lynall","year":"2010","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01952426","article-title":"Suitability of urethane anesthesia for physiopharmacological investigations in various systems. part 1: general considerations","volume":"42","author":"Maggi","year":"1986","journal-title":"Experientia"},{"issue":"7","key":"10.1016\/j.neuropharm.2017.03.024_bib40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/jcbfm.2012.50","article-title":"Anesthesia and the quantitative evaluation of neurovascular coupling","volume":"32","author":"Masamoto","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archpsyc.62.4.379","article-title":"Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia","volume":"62","author":"Meyer-Lindenberg","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9 Pt B","key":"10.1016\/j.neuropharm.2017.03.024_bib42","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.neubiorev.2013.09.012","article-title":"Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: the CNTRICS initiative","volume":"37","author":"Millan","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2017.03.024_bib43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.03.024_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1745017901208010052","article-title":"Schizophrenia: from epidemiology to rehabilitation","volume":"8","author":"Mura","year":"2012","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2017.03.024_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2014.10.036","article-title":"Association between symptoms of psychosis and reduced functional connectivity of auditory cortex","volume":"160","author":"Oertel-Knochel","year":"2014","journal-title":"Schizophrenia Res."},{"issue":"13","key":"10.1016\/j.neuropharm.2017.03.024_bib46","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1073\/pnas.89.13.5951","article-title":"Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging","volume":"89","author":"Ogawa","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.03.024_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/mrm.26496","article-title":"Resting-state functional MRI as a tool for evaluating brain hemodynamic responsiveness to external stimuli in rats","author":"Paasonen","year":"2016","journal-title":"Magnetic Reson. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.03.024_bib48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.euroneuro.2015.12.034","article-title":"Comparison of seven different anesthesia protocols for nicotine pharmacologic magnetic resonance imaging in rat","volume":"26","author":"Paasonen","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.03.024_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2017.03.024_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00207450109149737","article-title":"Functional connectivity and working memory in schizophrenia: an EEG study","volume":"106","author":"Peled","year":"2001","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00008877-200502000-00003","article-title":"Performance of male C57BL\/6J mice and wistar rats in the water maze following various schedules of phencyclidine treatment","volume":"16","author":"Podhorna","year":"2005","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ajp.159.2.227","article-title":"A\u00a0PET study of the pathophysiology of negative symptoms in schizophrenia. positron emission tomography","volume":"159","author":"Potkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2017.03.024_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3649","article-title":"Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap","volume":"11","author":"Pratt","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.neuropharm.2017.03.024_bib54","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1073\/pnas.84.21.7744","article-title":"3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine","volume":"84","author":"Reynolds","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib55","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00213-005-2204-8","article-title":"Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia","volume":"180","author":"Risterucci","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/schbul\/sbu097","article-title":"Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia","volume":"41","author":"Rolland","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"12","key":"10.1016\/j.neuropharm.2017.03.024_bib57","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1176\/appi.ajp.157.12.2040","article-title":"Exploring the social brain in schizophrenia: left prefrontal underactivation during mental state attribution","volume":"157","author":"Russell","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2017.03.024_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bcpt.12090","article-title":"Pharmacological characterisation of a structurally novel alpha2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models","volume":"113","author":"Sallinen","year":"2013","journal-title":"Basic & Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.1999.10.1.59","article-title":"Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity","volume":"10","author":"Sams-Dodd","year":"1999","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2017.03.024_bib61","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","article-title":"Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine","volume":"69","author":"Santana","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2011.08.027","article-title":"Impaired social interaction and enhanced sensitivity to phencyclidine-induced deficits in novel object recognition in rats with cortical cholinergic denervation","volume":"195","author":"Savage","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib63","doi-asserted-by":"crossref","first-page":"427267","DOI":"10.5402\/2012\/427267","article-title":"Beyond dopamine: glutamate as a target for future antipsychotics","volume":"2012","author":"Sendt","year":"2012","journal-title":"ISRN Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2017.03.024_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(87)91606-4","article-title":"The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine\/sigma-receptor","volume":"435","author":"Sircar","year":"1987","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.03.024_bib65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-011-2277-5","article-title":"A\u00a0comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory","volume":"217","author":"Smith","year":"2011","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2017.03.024_bib66","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tips.2014.05.001","article-title":"Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery","volume":"35","author":"Smucny","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.03.024_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/schbul\/sbn176","article-title":"Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring","volume":"35","author":"Stephan","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.neuropharm.2017.03.024_bib68","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.biopsych.2005.10.005","article-title":"Synaptic plasticity and dysconnection in schizophrenia","volume":"59","author":"Stephan","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.03.024_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2014.09.050","article-title":"Neural circuitry for rat recognition memory","volume":"285","author":"Warburton","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"4\u20136","key":"10.1016\/j.neuropharm.2017.03.024_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.brainresbull.2006.06.007","article-title":"Negative symptoms: a review of schizophrenia, melancholic depression and parkinson's disease","volume":"70","author":"Winograd-Gurvich","year":"2006","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.03.024_bib71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1471-4159.1988.tb13260.x","article-title":"3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes","volume":"50","author":"Wong","year":"1988","journal-title":"J.\u00a0Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T20:00:51Z","timestamp":1658865651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":71,"alternative-id":["S0028390817301132"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.024","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}